Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus.
about
Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaquesDNA vaccines: designing strategies against parasitic infectionsDNA immunization with hepatitis C virus (HCV) polycistronic genes or immunization by HCV DNA priming-recombinant canarypox virus boosting induces immune responses and protection from recombinant HCV-vaccinia virus infection in HLA-A2.1-transgenic miProtection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens.Development of DNA vaccines against hemolytic-uremic syndrome in a murine model.In-situ crosslinking hydrogels for combinatorial delivery of chemokines and siRNA-DNA carrying microparticles to dendritic cells.Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites.Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine.Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice.Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations.Protection of rhesus macaques against lethal Plasmodium knowlesi malaria by a heterologous DNA priming and poxvirus boosting immunization regimenA vesicular stomatitis virus recombinant expressing granulocyte-macrophage colony-stimulating factor induces enhanced T-cell responses and is highly attenuated for replication in animalsIdentification of two new protective pre-erythrocytic malaria vaccine antigen candidates.Expression of CCL20 and granulocyte-macrophage colony-stimulating factor, but not Flt3-L, from modified vaccinia virus ankara enhances antiviral cellular and humoral immune responses.A DNA prime-modified vaccinia virus ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge.Induction of protective immunity against Schistosoma mansoni via DNA priming and boosting with the large subunit of calpain (Sm-p80): adjuvant effects of granulocyte-macrophage colony-stimulating factor and interleukin-4.DNA immunization with the cysteine-rich interdomain region 1 of the Plasmodium falciparum variant antigen elicits limited cross-reactive antibody responses.Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines.Immunotherapeutic strategies for malignant glioma.The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses.Immunotherapy of cancer in 2012.Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization.Rational design of gene-based vaccines.Genetic vaccination approaches against malaria based on the circumsporozoite protein.Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNAHigh road, low road? Choices and challenges on the pathway to a malaria vaccine.Combination vaccines: synergistic simultaneous induction of antibody and T-cell immunity.Proteomic analysis of and immune responses to Ehrlichia chaffeensis lipoproteinsThe potential of topical DNA vaccines adjuvanted by cytokines.Viral vectors in malaria vaccine development.Plasmodium knowlesi: a relevant, versatile experimental malaria model.Cellular immune response to DNA and vaccinia prime-boost immunization kills Plasmodium yoelii-infected hepatocytes in vitro.Study of canine parvovirus evolution: comparative analysis of full-length VP2 gene sequences from Argentina and international field strains.Reduced immunogenicity of DNA vaccine plasmids in mixtures.Prime-boost vaccines encoding an intracellular idiotype/GM-CSF fusion protein induce protective cell-mediated immunity in murine pre-B cell leukemia.Immune responses elicited by co-immunization of Plasmodium vivax and P. falciparum MSP-1 using prime-boost immunization strategies.Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF.
P2860
Q24548638-809F7F41-CC03-42B5-AB8D-3434206AC504Q24801950-F1DCFEBF-E9B1-4C1D-85CA-38EA2EA30FA1Q27473069-51B3690C-A20F-48BC-A8E2-A0B635B93927Q33303670-7C4D020A-800B-4A41-AA5D-DB1DEC1E2668Q33348633-BD5A32CD-9FBA-44EA-8B09-5347192D7C4AQ33635879-5C4780E0-319A-44CD-B639-A5722F72106DQ33768911-79985592-BB46-43A9-A9A8-0B1670B89B5DQ33943869-0E88D87D-FF3C-4EF2-954C-E7CC89B200DBQ34007894-FB181B0E-933C-4E70-9F6E-CD132B13DE4EQ34126483-3845768C-DC76-462B-AE05-79DCEEF2DBF0Q34129094-39BB947D-EA9F-4F4A-939E-811BBA4BF523Q34228558-BEACB093-65FD-4A42-918B-0F59FDA44812Q34778655-2A4675F9-FC12-4531-80E0-97ADCB98B91DQ35023778-CFD55E85-B936-4B3A-8ADA-02065AD14884Q35073970-250E267E-789C-44D7-AE11-6F4E3A43E0BDQ35105822-DAA655EC-CB9E-4AA6-92CF-698265FAE778Q35165007-BE2C3619-8AE1-4FBD-BE6D-33F4D6F873F0Q35182263-8C441F84-6880-46EF-8E59-F474D7C5D907Q35778576-B01C9BC0-FD6B-40A0-96EC-5497A3678EEAQ35951849-AECE5270-0CCC-4A99-BE56-4C9A1C830305Q36243536-9378F3C9-A5B8-402C-8A31-1AAD850E97BCQ36285998-EE690B68-AFE2-4E56-A52C-73DBB6A67709Q36346123-6E86A5DD-EB25-49EA-9774-A68C10407018Q36666591-4C3B2AF1-DC49-480A-AF94-B3478AEC8600Q36694820-A51AB6BB-D342-44A9-90DE-776392DEEDBAQ36726723-916B3788-2DF6-4B00-9D9F-FE824603E78DQ36728808-44F78C71-C748-47DA-8C27-5ACEAD614B12Q36804309-A3338791-DF11-4682-AEEE-B6076C107FA8Q36960508-AC1516F6-E998-480D-A201-4C6B27BF949DQ37582425-560B8FA7-5F1A-4548-A82D-AC8DB46E0039Q38784765-F3D2D23A-3EEE-4066-BDB3-C871B54D8778Q40213640-A44B4D75-F3A3-4591-8057-40D79F81592EQ45720843-C395A8FF-91FC-420A-86E2-A7C3246443A1Q45872945-4976A300-AFFB-4C71-A140-52413906D35EQ45885024-7A91E835-8AC3-4F85-AAA5-35EA41A3206AQ47989426-D7CAD531-7AC4-4F04-B47C-E3A442EC85FCQ51629833-8ED5F383-A5DD-4FE4-AAF3-B299E294BEA9
P2860
Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Improving protective immunity ...... pressing recombinant poxvirus.
@ast
Improving protective immunity ...... pressing recombinant poxvirus.
@en
type
label
Improving protective immunity ...... pressing recombinant poxvirus.
@ast
Improving protective immunity ...... pressing recombinant poxvirus.
@en
prefLabel
Improving protective immunity ...... pressing recombinant poxvirus.
@ast
Improving protective immunity ...... pressing recombinant poxvirus.
@en
P2093
P1476
Improving protective immunity ...... pressing recombinant poxvirus.
@en
P2093
Charoenvit Y
Hedstrom R
Sacci JB Jr
P304
P356
10.4049/JIMMUNOL.164.11.5905
P407
P577
2000-06-01T00:00:00Z